She had done everything right. The Mediterranean diet since her late forties. A 45-minute walk four mornings a week. A glass of red wine on weekends — no more. She was not the person who'd "let herself go." She was, by any reasonable measure, a woman who paid attention to her health.

Then she sat down at her annual physical and heard her doctor read her numbers back to her.

Her total cholesterol: up 34 points from the year before. Her blood pressure: 134 over 86, when it had been 118 over 74 two years ago. Her doctor leaned back, wrote something on a clipboard, and said the sentence that nearly a million women a year hear in exam rooms across the United States:

She drove home, sat in her driveway, and did not go inside for fifteen minutes. Not because the numbers were catastrophic. Because nobody had told her why they had moved. She had not changed. She had not become careless. And yet, quietly, without her permission, something had shifted inside her body — and the medical establishment had just told her to watch it happen.

If any version of that story sounds familiar, this article is for you. Not to frighten you. Not to sell you something in the first paragraph. But because you deserve an explanation that nobody gave you in that exam room.

The number that changed everything — and the explanation that didn't come with it

Women in the United States are diagnosed with heart disease at lower rates than men for most of their lives. Then, somewhere in their early fifties, that gap narrows. By 65, the rates are nearly equal. By 75, women have overtaken men.

The American Heart Association has described the menopause transition as a key cardiovascular prevention window — a period when changes in lipids, blood pressure, body composition, and vascular function happen in ways that meaningfully alter a woman's long-term heart-health trajectory.

1 in 3 Women in the U.S. will develop cardiovascular disease in their lifetime — the leading cause of death in women over 50

10 yrs Average gap between when cardiovascular risk accelerates in women and when it is formally discussed in a primary care setting

80% Of cardiovascular events in women may be preventable with early lifestyle and biological intervention, per AHA data

Most women know none of this. Not because they haven't been

 paying attention — but because nobody told them. Cardiology research, for most of the twentieth century, was conducted almost entirely on men. The FDA didn't require women to be included in clinical trials until 1993. The downstream effects of that omission are still being felt today: diagnostic tools calibrated to male presentations of disease, guidelines built on male biology, and a generation of female patients whose cardiovascular changes in midlife were systematically understudied.

That is not a conspiracy. It is a history of neglect — of a medical establishment that was slow, systematically slow, to ask the questions women needed answered. And it is why you may have sat in an exam room at 56 and been handed a cholesterol printout with no explanation of why menopause is, at a biological level, a cardiovascular event.

"I've tried everything. My habits are the same. Why are my numbers moving?"

This is the question that women in midlife ask most — not in doctors' offices, where the appointments are four minutes, but in the comments sections of Dr. Mary Claire Haver's videos. In the threads on r/Menopause. In the Goodreads reviews of Outlive and The New Menopause, where women write in full paragraphs about the frustration of researching their own condition because their healthcare providers don't have the time.

The frustration is almost always the same: I haven't changed. So why has everything else?

The answer — the one your doctor likely didn't have time to give you, or didn't know how to frame — has to do with a molecule you've probably never thought about. A molecule that, for roughly forty years of your life, was quietly doing some of the most important work in your cardiovascular system. And that menopause, specifically, takes away a critical part of its power supply.

That molecule is nitric oxide. And understanding what it does — and what happens to it after menopause — is the beginning of a real explanation for what you've been experiencing.

· · ·

The molecule your body has been making since before you were born

Nitric oxide is produced inside the cells that line your blood vessels. Its primary job is deceptively simple: it tells your blood vessels to relax. When your vessels relax, blood moves through them more easily. Pressure drops. Flow improves. Your cardiovascular system does its work with less effort.

It does other things too — things that researchers are still mapping. It plays a role in preventing platelets from clumping where they shouldn't. It helps regulate inflammation inside the vessel wall. It is, in the words of the three researchers who won the 1998 Nobel Prize in Physiology or Medicine for its discovery, a signaling molecule of extraordinary importance — one that the body had been quietly deploying for millions of years before science understood what it was.

For most of your adult life, your body produced this molecule primarily through one pathway. It runs inside the endothelial cells lining your vessel walls, and it requires an enzyme called eNOS — endothelial nitric oxide synthase — to work. That enzyme, it turns out, is powerfully stimulated by estrogen.

This is the part of the story most women never hear. Estrogen, among its many roles in the female body, is a major driver of nitric oxide production. The same hormone that declines sharply at menopause is also one of the primary signals that tells your blood vessels to stay relaxed, to stay flexible, to stay healthy.

Which means that when estrogen falls — not gradually, not gently, but in the precipitous drop that characterizes the menopause transition — your body's primary nitric oxide production pathway loses much of its power supply.

Your habits didn't change. Your cholesterol wasn't suddenly higher because you started eating differently. Your blood pressure didn't creep up because you stopped caring. What changed was the internal signal — the one that had been running quietly in the background for four decades — that helped keep your vascular system in balance.

Why everything you've already tried may have addressed the wrong problem

When women describe what they've done about their cardiovascular trajectory after menopause, the list is usually long and serious. They've changed their diets. They've added more walking, more strength training. They've taken the supplements their friends recommended — CoQ10, omega-3s, magnesium, the menopause supplements that promised to address "midlife health." They've researched statins, researched HRT, argued with themselves for months about which is safer.

And then, at the next physical, the numbers have held or drifted further. And the explanation they received — "these things take time," "let's give it another six months" — felt exactly as unsatisfying as the first one.

Here is what most of those interventions share: they do not address the nitric oxide pathway directly.

A low-cholesterol diet can reduce the burden on your vascular system. Omega-3s support the health of vessel walls. Exercise improves how efficiently blood moves. These are all valuable — and none of them are wrong. But they address the downstream effects. The menopause-specific mechanism — the collapse of the estrogen-driven nitric oxide pathway — keeps running in the background, unaddressed, while women work harder and harder at inputs that weren't built for this specific biological change.

The hot-flash supplements are in a different lane entirely. They were designed for vasomotor symptoms — the heat, the disrupted sleep, the night sweats that make the menopause transition so disruptive for millions of women. Those are real problems. But they are not cardiovascular problems. Bonafide, Womaness, O Positiv — these brands were built around the symptoms most women complained about loudest in 2015 and 2020. The cardiovascular conversation was quieter. It was happening in research labs and cardiology departments and the comments sections of Peter Attia podcasts — not in supplement marketing.

This is not an indictment of those products. It is an observation about a gap. A specific, postmenopausal cardiovascular gap that the supplement industry, until very recently, was not addressing in any serious way — and that most women navigating this territory are trying to fill alone, with books and podcasts and research they're doing themselves because their four-minute appointments aren't enough.

There is a second pathway. And almost nobody is talking about it.

Here is the part of the story that almost never makes it into a primary care appointment. The part that was discovered in a research laboratory in Sweden in the 1990s, confirmed over the following two decades, and that became clinically meaningful for postmenopausal women only recently — when researchers finally started asking the right question.

Your body does not have just one way to make nitric oxide. It has two.

The first is the one you just read about — the L-arginine pathway, driven by eNOS, powered in significant part by estrogen. This is the main road. The one your cardiovascular system has run on for decades. And the one that menopause dims.

The second pathway is different in a fundamental way. It does not require estrogen to function. It runs on something entirely separate — something your body has been capable of using since birth, but that most women have never been told about, and that most supplement brands have never built around.

It runs on dietary nitrate.

Dietary nitrate — found in its highest concentrations in beetroot and dark leafy greens — follows a different route through the body. It is converted, first in the mouth and then in the stomach, into nitrite. Nitrite is then converted into nitric oxide through a process that does not depend on eNOS. It does not depend on endothelial health. And critically — it does not depend on estrogen.

This pathway was mapped in detail by a research team at the Karolinska Institute in Sweden, led by Jon Lundberg and Eddie Weitzberg, working through the late 1990s and into the 2000s. Their work established that the nitrate-nitrite-NO pathway is a real, functional, biologically significant second route to the same protective molecule. For years, it sat at the edges of mainstream cardiology — too nutritional to feel like medicine, too mechanistic to feel like wellness.

Until researchers started asking the question that had, somehow, been missed for a generation: what happens when you give postmenopausal women — the population whose primary nitric oxide pathway has lost its estrogen driver — access to this second route?

In June 2024, researchers publishing in Frontiers in Nutrition gave that question its clearest answer yet.

This is the science that most postmenopausal women have never heard. The pathway your body still has. The one that doesn't require estrogen, doesn't require medication, doesn't require any of the difficult trade-off conversations around HRT or statins. The one that runs on something as unglamorous — and as real — as what you eat.

Your habits didn't change. But now, for the first time, you have a reason to change one specific thing — not because you did anything wrong, but because your body entered a new phase that has a specific biological consequence, and that consequence has a specific, research-supported, daily response.

How the two pathways actually work — and why the second one changes the conversation

It helps to see this as a diagram rather than a description. For most of your adult life, your body ran two routes to the same destination simultaneously. After menopause, the first route loses its primary driver. The second route stays open — but only if you give it the fuel it needs.

The second pathway does not replace the first. It supplements it. It gives your body a parallel route to the same protective signaling molecule — one that functions whether estrogen is present or not, whether you are one year or twenty years past your final period.

The question, then, is a practical one: how do you give that second pathway consistent, standardized, daily fuel? You could eat very large amounts of raw beetroot and dark leafy greens every single day — roughly two large beets or the equivalent in spinach. Most women don't. Most women won't. Not because they lack discipline, but because the logistics of maintaining that specific intake, every day, against a background of everything else life requires, are not realistic.

This is the problem that Purevia Beetroot was built to solve.

Why Purevia is built differently from every other beetroot product on the market

There are beetroot supplements on the market. HumanN SuperBeets. Force Factor Total Beets. Berkeley Life. Cardio Miracle. Most of them have been around for years, are sold to men and women of all ages, and are built around beetroot powder weight — not dietary nitrate content.

This distinction matters more than it might appear. A product can list "500mg of beetroot powder" on its label and contain almost any amount of actual dietary nitrate — because the nitrate content of raw beetroot varies widely depending on how it was grown, how long it was stored, and how the powder was processed. Listing powder weight without standardizing for nitrate content is like listing "500mg of orange powder" and calling it a vitamin C supplement.

The research on dietary nitrate and vascular function — including the 2024 Penn State study in postmenopausal women — was conducted using controlled, measurable doses of actual dietary nitrate. Not powder weight. If a supplement doesn't standardize for nitrate content, it cannot make a credible connection to that research.

The questions Linda asks before she buys anything

If you are the kind of woman who reads the label, researches the ingredients, and wants actual answers before you spend money on something — this section is for you.

What it looks like when this actually works

Clinical language can only take you so far. What women actually want to know is what this feels like — not in a laboratory, but in the life of a 56-year-old woman with a job, a family, a next physical in six months, and a mother's death still in the back of her mind as the thing she is quietly working against.

Picture what a different conversation looks like

Not a dramatic turnaround. Not a before-and-after. Something quieter and more honest than that.

Picture sitting down at your next physical and feeling, for the first time, like you walked in having done something specific — not just hoping, not just "watching" — but having actively supported the mechanism that your body lost access to. Your doctor reads the numbers. Whatever they are, you understand the biology behind them in a way you didn't twelve months ago. You are in the conversation. You are no longer the person sitting in the parking lot.

Picture being the grandmother who shows up. Not the one whose family got a call. Not the one who waited for a crisis to be the wake-up call. The one who started doing something at 56, while she still could, and who was still sharp and mobile and present at 76 — at every recital, every graduation, every ordinary Tuesday that compounds into a life.

Picture your next physical being, in the words of the women who describe their greatest wish about their health: boring. A boring physical. Numbers that hold. A doctor who says "whatever you're doing, keep doing it." That is the whole thing. That is all of it.

That is what six months of consistency, of one capsule a day, of finally addressing the mechanism instead of watching it from a distance, looks like in real life. Not miraculous. Not instantaneous. But directional, measurable, and yours.

Try Purevia Beetroot for 60 Days — Risk Free

Nitrate-standardized. Third-party tested. Built for postmenopausal women who read the label and want a real mechanism behind what they take daily.

Start My First Month

60-day full refund — used or unused, no questions asked.

Subscribe & save · Cancel anytime · No phone required